Folks stroll by a CVS Pharmacy retailer within the Manhattan borough of New York Metropolis.Shannon Stapleton | ReutersCVS Well being reported a ro
Folks stroll by a CVS Pharmacy retailer within the Manhattan borough of New York Metropolis.
Shannon Stapleton | Reuters
CVS Well being reported a robust first quarter and raised its full-year forecast, as clients got here to its shops for Covid-19 vaccinations, assessments and prescriptions.
Shares of the corporate have been up 3% early Tuesday in premarket buying and selling.
This is what the corporate reported for the fiscal first quarter ended March 31, in contrast with what analysts have been anticipating, primarily based on a survey of analysts by Refinitiv:
- Earnings per share: $2.04, adjusted vs. $1.72 anticipated
- Income: $69.1 billion vs. $68.39 billion anticipated
The health-care firm and drugstore chain reported internet earnings of $2.22 billion, or $1.68 per share, up from $2.01 billion, or $1.53 per share, a yr earlier.
Excluding objects, it earned $2.04 per share, greater than the $1.72 per share anticipated by analysts surveyed by Refinitiv.
Income rose to $69.1 billion from $66.eight billion a yr earlier. That outpaced analysts’ expectations of $68.39 billion.
CVS is a serious supplier of Covid-19 vaccines and lately started providing same-day appointments for the pictures.
As of Monday’s shut, shares of CVS have been up almost 14% this yr. They closed at $77.69 on Monday, bringing the corporate’s market worth to $101.97 billion.
Learn full launch right here.
This story is creating. Please verify again for updates.